ProShare Advisors
AMTI

ProShare Advisors’s Applied Molecular Transport Inc. Common Stock AMTI Stock Holding History

ProShare Advisors’s Portfolio AMTI Stock Details AMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,885
Closed -$152K – 2328
2021
Q4 		$152K Sell
10,885
-527
-5% -$10.4K ﹤0.01% 2123
2021
Q3 		$295K Sell
11,412
-1,847
-14% -$58.5K ﹤0.01% 1564
2021
Q2 		$606K Buy
13,259
+2,497
+23% +$118K ﹤0.01% 1387
2021
Q1 		$474K Buy
10,762
+2,630
+32% +$128K ﹤0.01% 1478
2020
Q4 		$250K Buy
+8,132
New +$258K ﹤0.01% 1733

Other funds holding AMTI

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FFVM
Founders Fund VI Management San Francisco, California $45.8K AUM 58.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ProShare Advisors's AMTI Position: Q1 2022 in Review

ProShare Advisors sold out of Applied Molecular Transport Inc. Common Stock (AMTI) in Q1 2022, closing a stake of 10,885 shares — an estimated $152K sold.

ProShare Advisors first reported a position in AMTI in Q4 2020 and held it in 5 quarters. The position peaked at $606K in Q2 2021. 77 funds tracked by Wall St. Rank hold AMTI as of Q1 2022.

  • ProShare Advisors reported no remaining Applied Molecular Transport Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • ProShare Advisors sold 10,885 Applied Molecular Transport Inc. Common Stock shares in Q1 2022, an estimated $152K.
  • ProShare Advisors first reported a position in Applied Molecular Transport Inc. Common Stock in Q4 2020 and held it in 5 quarters.
  • ProShare Advisors's Applied Molecular Transport Inc. Common Stock position peaked at $606K in Q2 2021.
  • 77 funds tracked by Wall St. Rank held Applied Molecular Transport Inc. Common Stock as of Q1 2022.

Based on ProShare Advisors's 13F filing for Q1 2022, filed 10 May 2022.